Chemours (CC) Other Accumulated Expenses (2015 - 2026)

Chemours' Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $97.0 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 17.09% year-over-year to $97.0 million; the TTM figure through Mar 2026 stood at $97.0 million (down 17.09% YoY), while the FY2025 annual figure was $150.0 million, up 30.43% from the prior year.
• Other Accumulated Expenses was $97.0 million for Q1 2026 at Chemours, down from $150.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $239.0 million in Q2 2022 to a low of $74.0 million in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $116.1 million across 5 years, with a median of $115.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 191.46% in 2022, then sank 52.72% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $74.0 million in 2022, then jumped by 74.32% to $129.0 million in 2023, then declined by 10.85% to $115.0 million in 2024, then jumped by 30.43% to $150.0 million in 2025, then tumbled by 35.33% to $97.0 million in 2026.
• The last three Other Accumulated Expenses figures came in at $97.0 million (Q1 2026), $150.0 million (Q4 2025), and $107.0 million (Q3 2025), per Business Quant data.